SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Ernest Hemingway — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientErnest Hemingway
Date of birth1899-07-21
IdentifiersMRN HR-ET003-SYN-TD; SSN (made up) 000-03-7419
Document date1955-08-31
AuthorWalter Brandt-Ochoa, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month review: iron, liver, mood, memory and blood pressure. [S]

History of Present Illness

Mr. Hemingway returns six months after intake. He has had twenty-two phlebotomies, and the twenty-third is planned after today's blood tests. He has had no alcohol for about fifteen weeks and still takes naltrexone. His mood is steady; the monthly PHQ-9 with the behavioral health clinician was 6 at his preventive visit and is 5 today. He writes every morning and says names and words come to him more easily. Headaches are about once a week. On amlodipine 10 mg his home average is 124/76, with slight ankle swelling in the evenings. The echocardiogram was done this morning. His guns remain at the club; he would like to bring them home before the autumn shooting season, and this was discussed. [S]

ElementDetail
PhlebotomyTwenty-two sessions; the twenty-third today
AlcoholNone for about fifteen weeks; AUDIT-C 0
MoodPHQ-9 5; item 9 scored 0
Home blood pressureAverage 124/76 on amlodipine 10 mg
CognitionMoCA 27, from 25

Review of Systems

SystemResultFinding
ConstitutionalNegativeMore energy; weight down 5 kg since intake
CardiovascularPositiveSlight ankle swelling in the evenings; no chest pain or breathlessness
NeurologicalPositiveHeadaches about once a week; memory better
PsychiatricNegativeMood steady; no thoughts of suicide or wishes to be dead since the last visit

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinkingOne tablet dailyOral route1955-03-02activeS
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-03-02 to 1955-08-31completedS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-03-02 to 1955-04-13completedS
Sertraline 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-04-13activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-03-02 to 1955-06-08completedS
Amlodipine 10 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-06-08activeS
Cephalexin 500 mg oral capsule, one capsule four times daily for seven daysOne capsule four times daily for seven daysOral route1955-05-11 to 1955-05-18completedS
Doxycycline hyclate 100 mg oral capsule, one capsule twice daily for seven days, with a full glass of water, sitting uprightOne capsule twice daily for seven daysOral route1955-05-11 to 1955-05-18completedS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for pain, no more than 2,000 mg a day while he is drinkingOne or two tablets every 6 hours as needed, up to 2,000 mg a dayOral route1955-05-11 to 1955-05-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1955-08-31Body height183cmS
1955-08-31Body weight92.8kgS
1955-08-31Body mass index (BMI) [Ratio]27.7kg/m2S
1955-08-31Systolic blood pressure126mm[Hg]S
1955-08-31Diastolic blood pressure78mm[Hg]S
1955-08-31Heart rate72/minS
1955-08-31Respiratory rate14/minS
1955-08-31Body temperature36.6CelS
1955-08-31Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1955-08-31Hemoglobin [Mass/volume] in Blood13.4g/dL13.5-17.5 g/dLLowS
1955-08-31MCV [Entitic mean volume] in Red Blood Cells by Automated count93fL80-100 fLNormalS
1955-08-31Platelets [#/volume] in Blood by Automated count22610*3/uL150-400 10*3/uLNormalS
1955-08-31Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L10-40 U/LNormalS
1955-08-31Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-55 U/LNormalS
1955-08-31Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma41U/L8-61 U/LNormalS
1955-08-31Iron [Mass/volume] in Serum or Plasma148ug/dL65-175 ug/dLNormalS
1955-08-31Iron saturation [Mass Fraction] in Serum or Plasma44%20-50%NormalS
1955-08-31Ferritin [Mass/volume] in Serum or Plasma268ng/mL24-336 ng/mLNormalS
1955-08-31Cholesterol [Mass/volume] in Serum or Plasma194mg/dL<=199 mg/dLNormalS
1955-08-31Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation114mg/dL<=129 mg/dLNormalS
1955-08-31Cholesterol in HDL [Mass/volume] in Serum or Plasma49mg/dL>=40 mg/dLNormalS
1955-08-31Triglyceride [Mass/volume] in Serum or Plasma136mg/dL<=149 mg/dLNormalS
1955-08-31Hemoglobin A1c/Hemoglobin.total in Blood5.9%4-5.6%HighS
1955-08-31Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1955-08-31Total score [AUDIT-C]0{score}S
1955-08-31Total score [MoCA]27{score}S

Physical Exam

Vital signs recorded on 1955-08-31; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 126/78, pulse 72; weight 92.8 kg
CardiovascularRegular rhythm; no murmur; trace ankle edema
AbdomenLiver not palpable; no spleen felt
NeurologicalNo tremor; gait normal
PsychiatricBright, humorous and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe; heavy daily drinking for most of his adult life; synthetic modern episode linked to his documented heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding of DSM-5-TR severe alcohol use disorder (seven criteria); person-first language; not a claim about his real diagnosis.
Raised transferrin saturation and ferritin found on routine intake tests, cause not yet known (heavy drinking, liver disease or iron overload)resolvedconfirmed R79.0S — Synthetic presenting finding; superseded when HFE testing gave the diagnosis.
Hereditary hemochromatosis, HFE C282Y homozygous, with iron overload (ferritin over 1,000 ng/mL) and no advanced liver fibrosis on imagingactiveconfirmed E83.110S — Synthetic modern diagnosis. Whether he had hemochromatosis is disputed (CLM-0013); the modern diagnosis is not offered as proof of it.
Major depressive disorder, single episode, moderate; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about his real mood. The roster's bipolar disorder lead is disputed (CLM-0014) and is not used.
Essential hypertension, stage 2, with heavy drinking contributingactiveconfirmed I10S — Synthetic modern diagnosis confirmed by home readings.
Post-concussion symptoms (headaches, slowed thinking and forgetfulness) after repeated head injuries, most recently a concussion with a skull fracture a year ago; chronic traumatic encephalopathy is not diagnosedactiveconfirmed F07.81S — Synthetic modern diagnosis anchored to his documented head injuries; alcohol and depression also affect the symptoms.
Prediabetes (HbA1c 6.1%)activeconfirmed R73.03S — Synthetic finding on diabetes screening; iron overload and alcohol both raise the risk of diabetes.
Fishhook puncture wound of the right hand with early cellulitis after saltwater exposure, in a man with iron overload; treated with antibiotics covering Vibrio; resolvedresolvedconfirmed L03.113S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryHemoglobin before each phlebotomy (hold if under 12.0 g/dL)Before every session; full blood count at visitsCompleted todayHemoglobin 13.4 g/dL, MCV 93 fL, platelets 226
LaboratorySerum ferritin during induction phlebotomyAt diagnosis, then about every 10 to 12 phlebotomies; target 50 to 100 ng/mLCompleted todayFerritin 268 ng/mL after twenty-two sessions
LaboratoryTransferrin saturationAt diagnosis and as ferritin nears targetCompleted todaySerum iron 148 ug/dL; transferrin saturation 44%
Medication safetyWeekly phlebotomy of 500 mLWeekly during inductionCompleted todayTwenty-two sessions; the twenty-third today
ImagingLiver cancer surveillanceEvery six months only with cirrhosis or advanced fibrosisNot indicatedNo advanced fibrosis
ImagingEchocardiogram for iron-related heart diseaseWhen symptoms or ECG changes, or with other cardiac indicationsCompleted todayDone today with the hypertension echocardiogram: no iron-related cardiomyopathy
Self-managementDiet: no iron or vitamin C supplements, no raw shellfishEvery visitCompleted todayNo supplements; no raw shellfish
LaboratoryLiver tests on naltrexoneBaseline, about one month, then every three to six monthsCompleted todayAST 27, ALT 31 and GGT 41 U/L; normal
SurveyDrinking quantity and goal (AUDIT-C, drinking diary)Every visitCompleted todayAUDIT-C 0; no alcohol for about fifteen weeks
Medication safetyOpioid use and pain plan on naltrexoneEvery visitCompleted todayNo opioids
Medication safetyThiamineWhile drinking or malnourishedCompleted todayStopped today
SurveyDepression (PHQ-9)At least monthly during acute treatmentCompleted todayPHQ-9 5, item 9 scored 0; monthly since the corrective action
Medication safetySertraline adherence and side effectsTwo weeks after starting or changing the dose, then each visitCompleted today100 mg; no side effects
SurveySuicide-risk review (C-SSRS screen since the last visit), safety plan, firearm storage and the 988 Suicide & Crisis LifelineEvery visitCompleted todayC-SSRS screen negative since the last visit; firearms remain off-site by his choice, with safe storage planned for their return
Self-managementPsychotherapy (CBT)Weekly, then every two weeksCompleted todayReduced to every two weeks
ExaminationBlood pressure, home readings, weight and cardiac auscultationEvery visitCompleted today126/78 in clinic; home average 124/76; weight 92.8 kg; trace ankle edema
ImagingEchocardiogramAt diagnosis of stage 2 hypertensionCompleted todayDone this morning after the corrective action: mild concentric left ventricular hypertrophy, ejection fraction 60%
LaboratoryLipid panelYearlyCompleted todayTotal cholesterol 194, LDL 114, HDL 49 and triglycerides 136 mg/dL
LaboratoryUrine albumin-to-creatinine ratioYearlyUp to date14 mg/g at intake
LaboratoryHbA1cAt diagnosis of prediabetes, then every six to twelve monthsCompleted todayHbA1c 5.9%
SurveyCognitive screen (MoCA)Baseline, then after three months with less or no alcoholCompleted todayMoCA 27 of 30, from 25; delayed recall improved
ExaminationPost-concussion symptoms (headache frequency, sleep, concentration)Every visitCompleted todayHeadaches about once a week
ImagingBrain imagingOnly for warning signs or declineNot indicatedNo warning signs; cognition improving

Goal progress:

Guideline basis: Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases (2011); ACG Clinical Guideline: Hereditary Hemochromatosis (2019); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); VA/DoD Clinical Practice Guideline for the Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury (2021); Prediabetes and Type 2 Diabetes: Screening (2021); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)

Follow-up: Weekly phlebotomy until ferritin is 50 to 100 ng/mL, then maintenance. Review in three months. Psychotherapy every two weeks and monthly PHQ-9. Colonoscopy as scheduled. [S]